Free Trial

Longevity Health (XAGE) Competitors

Longevity Health logo
$3.99 +0.36 (+9.92%)
As of 04:00 PM Eastern

XAGE vs. INBS, XAIR, MHUA, WOK, LYRA, DHAI, BTCY, PAVM, SSKN, and CODX

Should you be buying Longevity Health stock or one of its competitors? The main competitors of Longevity Health include Intelligent Bio Solutions (INBS), Beyond Air (XAIR), Meihua International Medical Technologies (MHUA), WORK Medical Technology Group (WOK), Lyra Therapeutics (LYRA), DIH Holding US (DHAI), Biotricity (BTCY), PAVmed (PAVM), Strata Skin Sciences (SSKN), and Co-Diagnostics (CODX). These companies are all part of the "medical equipment" industry.

Longevity Health vs. Its Competitors

Longevity Health (NASDAQ:XAGE) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability and dividends.

Intelligent Bio Solutions has higher revenue and earnings than Longevity Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Longevity Health$50K79.80-$10.37MN/AN/A
Intelligent Bio Solutions$3.11M4.51-$10.16MN/AN/A

Longevity Health has a beta of 0.49, meaning that its share price is 51% less volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.6, meaning that its share price is 360% more volatile than the S&P 500.

24.2% of Longevity Health shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 29.0% of Longevity Health shares are owned by company insiders. Comparatively, 0.3% of Intelligent Bio Solutions shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Intelligent Bio Solutions has a net margin of -319.85% compared to Longevity Health's net margin of -1,535.11%. Longevity Health's return on equity of 0.00% beat Intelligent Bio Solutions' return on equity.

Company Net Margins Return on Equity Return on Assets
Longevity Health-1,535.11% N/A -280.07%
Intelligent Bio Solutions -319.85%-176.55%-93.89%

In the previous week, Intelligent Bio Solutions had 1 more articles in the media than Longevity Health. MarketBeat recorded 6 mentions for Intelligent Bio Solutions and 5 mentions for Longevity Health. Intelligent Bio Solutions' average media sentiment score of 0.89 beat Longevity Health's score of 0.23 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Longevity Health
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Intelligent Bio Solutions
3 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Intelligent Bio Solutions beats Longevity Health on 8 of the 11 factors compared between the two stocks.

Get Longevity Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for XAGE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XAGE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

XAGE vs. The Competition

MetricLongevity HealthSurgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ Exchange
Market Cap$3.99M$150.00M$2.16B$9.44B
Dividend YieldN/AN/A2.59%4.04%
P/E RatioN/AN/A22.1319.80
Price / Sales79.8027.7496.1389.12
Price / CashN/A3.6328.2128.17
Price / Book-0.591.4157.245.70
Net Income-$10.37M-$66.04M-$121.56M$257.84M
7 Day Performance51.14%8.59%0.99%1.87%
1 Month PerformanceN/A23.70%2.96%13.28%
1 Year PerformanceN/A603.74%24.44%19.15%

Longevity Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XAGE
Longevity Health
N/A$3.99
+9.9%
N/AN/A$3.99M$50K0.0014
INBS
Intelligent Bio Solutions
1.2584 of 5 stars
$2.15
+0.5%
N/A+40.5%$14.79M$3.11M0.0010
XAIR
Beyond Air
4.4415 of 5 stars
$3.26
+0.6%
$23.67
+626.0%
-71.3%$14.08M$3.71M-0.2170News Coverage
Analyst Upgrade
Gap Up
High Trading Volume
MHUA
Meihua International Medical Technologies
0.7478 of 5 stars
$0.45
+4.7%
N/A-53.1%$13.71M$96.90M0.00620Gap Up
WOK
WORK Medical Technology Group
N/A$0.79
-0.6%
N/AN/A$11.56M$11.51M0.00226Gap Up
LYRA
Lyra Therapeutics
2.5749 of 5 stars
$7.90
-7.6%
$100.00
+1,165.8%
-43.6%$11.33M$1.53M-0.1350
DHAI
DIH Holding US
0.442 of 5 stars
$0.25
+4.2%
N/A-92.5%$11.27M$64.47M-0.83N/AGap Up
High Trading Volume
BTCY
Biotricity
N/A$0.44
+12.6%
N/A-47.2%$10.85M$12.06M-0.4040Gap Up
High Trading Volume
PAVM
PAVmed
3.9633 of 5 stars
$0.60
+0.6%
$19.00
+3,049.3%
-40.3%$10.26M$1.99M0.8590
SSKN
Strata Skin Sciences
2.6533 of 5 stars
$2.20
-2.2%
$6.00
+172.7%
-39.4%$9.39M$33.56M-0.97120
CODX
Co-Diagnostics
3.7819 of 5 stars
$0.28
+1.5%
$5.50
+1,867.8%
-78.0%$9.38M$3.71M-0.24100High Trading Volume

Related Companies and Tools


This page (NASDAQ:XAGE) was last updated on 7/21/2025 by MarketBeat.com Staff
From Our Partners